A Study of Asciminib Safety and Efficacy in Young Adults With Chronic Myeloid Leukemia in the Gulf Region
Clinical trial NCT07681258 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07681258
- Sponsor
- Novartis Pharmaceuticals
- Status
- NOT_YET_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2026-09-30
- Primary completion
- 2027-06-30
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.